Meihua International Medical Technologies Reports 2024 Financial Results and Strategic Progress

Meihua International Medical Technologies Co., Ltd. ( (MHUA) ) just unveiled an announcement.

On April 25, 2025, Meihua International Medical Technologies Co., Ltd. announced its financial results for the fiscal year 2024. The company’s revenues slightly decreased to $96.91 million, primarily due to the disposal of Hainan Guoxie Technology Group Co. Ltd. Despite this, gross profit increased marginally, and the company maintained a stable gross margin of 34%. The company also highlighted its strategic initiatives, including the sale of its stake in Hainan Guoxie, progress on its medical industrial park in Hainan Province, and the launch of its AI-powered logistics platform. These efforts are part of the company’s focus on transitioning to premium consumables and intelligent healthcare products, which are expected to enhance its market positioning and operational efficiency.

Spark’s Take on MHUA Stock

According to Spark, TipRanks’ AI Analyst, MHUA is a Neutral.

Meihua International Medical Technologies has strong financial metrics and an undervalued stock price, but is challenged by technical indicators and cash flow issues. The lack of specific guidance from the earnings call leaves uncertainty about future performance, resulting in a moderate overall score.

To see Spark’s full report on MHUA stock, click here.

More about Meihua International Medical Technologies Co., Ltd.

Meihua International Medical Technologies Co., Ltd. is a reputable manufacturer and provider of Class I, II, and III disposable medical devices, operating primarily in China. The company focuses on advancing its strategic transition toward high-end medical products and enhancing operational efficiency.

YTD Price Performance: -14.86%

Average Trading Volume: 120,899

Technical Sentiment Signal: Buy

Current Market Cap: $7.78M

Learn more about MHUA stock on TipRanks’ Stock Analysis page.